A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.
Katrin LorenzYvonne SchellerKatharina BellFranz GrusKatharina A PontoFelix BockClaus CursiefenJens FlachMarta GehringTunde PetoRufino SilvaYossi TalNorbert PfeifferPublished in: Trials (2017)
EudraCT: 2014-000239-18; ClinicalTrials.gov, ID: NCT02947867 . (Registered on 15 October 2016); see also http://strong-nvg.com .